Abbvie - מכפיל P/S עתידי ABBV

Patent cliff risks and debt load at AbbVie Inc. (ABBV) are driving volatility, which the GURU.Markets daily chart reflects through the expected P/S ratio. The 2.80 mark indicates the current valuation level. To stabilize, the holding is developing partnerships with biotech startups, while a smooth CEO transition has helped maintain investor confidence in the business development strategy.

AbbVie Inc. maintains stability through effective portfolio rotation via the launch of new blockbusters and expansion into oncology. The issuer's forward P/S ratio assesses market value relative to expected sales, revealing demand resilience to macroeconomic shocks and the risk of a "value trap." Investors should compare pipeline growth rates with the price action on this chart to determine the optimal entry point for the asset.